Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on December 15, 2004
J Am Soc Nephrol 16: 514-519, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2004050409

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2004050409v1
16/2/514    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O’Hare, A. M.
Right arrow Articles by Chren, M.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O’Hare, A. M.
Right arrow Articles by Chren, M.-M.
Related Collections
Right arrowRelated Article

Epidemiology and Outcomes

Impact of Renal Insufficiency on Mortality in Advanced Lower Extremity Peripheral Arterial Disease

Ann M. O’Hare*, Daniel Bertenthal{ddagger}, Michael G. Shlipak{dagger},||, Saunak Sen|| and Mary-Margaret Chren§

* Divisions of Nephrology; {dagger} General Internal Medicine, Department of Medicine, {ddagger} Health Services Research Enhancement Award Program, § Department of Dermatology, VA Medical Center San Francisco; and || Department of Epidemiology and Biostatistics; and Department of Medicine, University of California, San Francisco, San Francisco, California

Address correspondence to: Dr. Ann M. O’Hare, Box 111J, Nephrology, VA Medical Center San Francisco, 4150 Clement Street, San Francisco, CA 94121. Phone: 415-221-4810 ext 4953; Fax: 415-750-6949; E-mail: Ann.O'Hare{at}med.va.gov

Renal insufficiency predicts mortality among patients who are treated for myocardial infarction and congestive heart failure, but its clinical significance in advanced peripheral arterial disease has not been evaluated. A national cohort of 5787 male veterans who received an initial diagnosis of rest pain, ischemic ulceration, or gangrene between January 1, 2000, and September 30, 2002, and had at least one serum creatinine measurement within 3 mo before diagnosis were identified. Sixty-two percent (n = 3561) of cohort members had normal or mildly reduced renal function (GFR ≥60 ml/min per 1.73 m2), 30% (n = 1742) had moderate renal insufficiency (GFR 30 to 59 ml/min per 1.73 m2), and 8% (n = 484) had severe renal insufficiency or renal failure (GFR <30 ml/min per 1.73 m2) but were not on dialysis. The percentages of patients who presented with gangrene or ischemic ulceration rather than rest pain increased with declining renal function (70, 77, and 87%; P < 0.001), as did 1-yr mortality risk (17, 27, and 44%; P < 0.001). After adjustment for demographic and clinical characteristics, patients with a GFR of 30 to 59 ml/min per 1.73 m2 (odds ratio, 1.32; 95% confidence interval, 1.13 to 1.53) and <30 ml/min per 1.73 m2 (odds ratio, 2.97; 95% confidence interval, 2.39 to 3.69) had a significantly increased odds of death within 1 yr of cohort entry. Both moderate and severe renal insufficiency are associated with an increased odds of death in patients with critical limb ischemia. Death rates were particularly high among those with a GFR <30 ml/min per 1.73 m2. This finding may be partly explained by their more frequent presentation with ischemic ulceration or gangrene rather than rest pain.


Related Article

This Month’s Highlights
J. Am. Soc. Nephrol. 2005 16: 279-283. [Full Text] [PDF]



This article has been cited by other articles:


Home page
VASC ENDOVASCULAR SURGHome page
K. I. Paraskevas, N. Bessias, J. Tzorbatzoglou, D. P. Mikhailidis, and V. Andrikopoulos
Effect of Statins on Renal Function in Patients With Peripheral Arterial Disease
Vascular and Endovascular Surgery, December 1, 2009; 42(6): 620 - 621.
[PDF]


Home page
Nephrol Dial TransplantHome page
Y. Kumada, T. Aoyama, H. Ishii, M. Tanaka, Y. Kawamura, H. Takahashi, T. Toriyama, T. Aoyama, Y. Yuzawa, S. Maruyama, et al.
Long-term outcome of percutaneous transluminal angioplasty in chronic haemodialysis patients with peripheral arterial disease
Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3996 - 4001.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
E. T Fung, A. M Wilson, F. Zhang, N. Harris, K. A Edwards, J. W Olin, and J. P Cooke
A biomarker panel for peripheral arterial disease
Vascular Medicine, August 1, 2008; 13(3): 217 - 224.
[Abstract] [PDF]


Home page
CJASNHome page
Y. P. Liew, J. R. Bartholomew, S. Demirjian, J. Michaels, and M. J. Schreiber Jr.
Combined Effect of Chronic Kidney Disease and Peripheral Arterial Disease on All-Cause Mortality in a High-Risk Population
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1084 - 1089.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Shadman, M. A. Allison, and M. H. Criqui
Glomerular Filtration Rate and N-Terminal Pro-Brain Natriuretic Peptide as Predictors of Cardiovascular Mortality in Vascular Patients
J. Am. Coll. Cardiol., June 5, 2007; 49(22): 2172 - 2181.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. H.H. Feringa, S. E. Karagiannis, M. Chonchol, R. Vidakovic, P. G. Noordzij, A. Elhendy, R. T. van Domburg, G. Welten, O. Schouten, J. J. Bax, et al.
Lower Progression Rate of End-Stage Renal Disease in Patients with Peripheral Arterial Disease Using Statins or Angiotensin-Converting Enzyme Inhibitors
J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1872 - 1879.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Guerrero, R. Montes, J. Munoz-Terol, A. Gil-Peralta, J. Toro, M. Naranjo, P. Gonzalez-Perez, C. Martin-Herrera, and A. Ruiz-Fernandez
Peripheral arterial disease in patients with stages IV and V chronic renal failure
Nephrol. Dial. Transplant., December 1, 2006; 21(12): 3525 - 3531.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K.-W. Mui, M. Sleeswijk, H. van den Hout, J. van Baal, G. Navis, and A.-J. Woittiez
Incidental Renal Artery Stenosis Is an Independent Predictor of Mortality in Patients with Peripheral Vascular Disease
J. Am. Soc. Nephrol., July 1, 2006; 17(7): 2069 - 2074.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
A. M. O'Hare, D. Bertenthal, A. N. Sidawy, M. G. Shlipak, S. Sen, and M.-M. Chren
Renal Insufficiency and Use of Revascularization among a National Cohort of Men with Advanced Lower Extremity Peripheral Arterial Disease
Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 297 - 304.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. M. O'Hare, A. B. Newman, R. Katz, L. F. Fried, C. O. Stehman-Breen, S. L. Seliger, D. S. Siscovick, and M. G. Shlipak
Cystatin C and Incident Peripheral Arterial Disease Events in the Elderly: Results From the Cardiovascular Health Study
Arch Intern Med, December 12, 2005; 165(22): 2666 - 2670.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP